SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
394biz.yahoo.comCasaubon-2/16/2000
393 Nothing new. biz.yahoo.com JB, how is handwriting practice going? MiljenkoMiljenko Zuanic-2/16/2000
392 HUMAN GENOME SCIENCES RECEIVES PATENT ON AIDS VIRUS ENTRY POINT hgsi.com Any sim1-2/16/2000
391 Heard that J.B. is writing a new book: "Want be a millionaire?" <Miljenko Zuanic-2/11/2000
390 Just parking, Medline search for P38 + COX-2 + prostaglandin. BTW, did anyone Miljenko Zuanic-2/8/2000
389 SOURCE: Glaxo Wellcome Studies Assess Safety, Efficacy and Resistance Profile oMiljenko Zuanic-2/2/2000
388 Sunday January 30, 3:00 pm Eastern Time Company Press Release SOURCE: Glaxo Wscaram(o)uche-1/30/2000
387 FWIW...... biz.yahoo.comscaram(o)uche-1/29/2000
386 Vol. 97, Issue 2, 734-739, January 18, 2000 Immunology IL-18 regulates IL-1-deMiljenko Zuanic-1/18/2000
385 I can't stop thinking about what and whose compounds (RZYM, VRTX, their ownMiljenko Zuanic-1/3/2000
384 My eyes deceive me.... this is beginning to look like respect?? - g - scaram(o)uche-1/3/2000
383 Thanks PB for link. No doubt, HCV drug development race will heat up in 2000, Miljenko Zuanic-12/30/1999
382 Speaking of compounds already in the clinic (and addressing potentially very laPseudo Biologist-12/30/1999
381 There is no doubt that product candidates are the name of the game for big pharBiotech Jim-12/23/1999
380 I agree, MZ, that a takeout price would have to be far more than current marketJohn Metcalf-12/23/1999
379 <<To me, this suggests companies like VRTX will be on more and more munchMiljenko Zuanic-12/23/1999
378 Big pharmas, as represented by ^DRG, are closing a down year, while various indJohn Metcalf-12/23/1999
377 >>I don't know if I buy that. [ * BTRN, BTRN, BTRN, BTRN, BTRN, BTRN WTDEC-12/23/1999
376 Probably takeover rumors. I've heard Boger won't sell out for anythirkrw-12/23/1999
375 >> Could be nothing more than what I would call "intra-sector" scaram(o)uche-12/23/1999
374 Rick, Could be nothing more than what I would call "intra-sector" arWTDEC-12/23/1999
373 This is wonderful. But.... why? (eom) scaram(o)uche-12/23/1999
372 Guffaw. Try looking at vestedinterests.com. (eom) scaram(o)uche-11/30/1999
371 Indeed, very nice deal. 1/3 of the worldwide (ex Japan) clinical expense (whicMiljenko Zuanic-11/29/1999
370 listened to the conference call..... just an incredible little deal, reflectiscaram(o)uche-11/29/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News